DEVELOPMENT OF CONTRACEPTIVES - OBSTACLES AND OPPORTUNITIES

被引：16
|
作者：
MASTROIANNI, L
DONALDSON, PJ
KANE, TT
机构：
[1] HOSP UNIV PENN,PHILADELPHIA,PA 19104
[2] POPULAT COUNCIL ASSOC,BANGKOK 10112,THAILAND
[3] CERPOD,INST SAHEL,BAMAKO,MALI
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1990年 / 322卷 / 07期
关键词：
D O I：
10.1056/NEJM199002153220732
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
On February 14, 1990, the National Research Council's Committee on Contraceptive Development released a report on a two-year study of the process by which contraceptives are developed and approved for use in the United States.* The committee was established on the basis of a request to the Committee on Population of the National Research Council and the Institute of Medicine and received support from the Andrew W. Mellon Foundation. Among the topics considered were the pace at which new products were being brought to the market, the effects of organizational and policy issues on the contraceptive-development process, and ways of. © 1990, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码：482 / 484
页数：3
相关论文
共 50 条
  • [1] Obstacles and opportunities in new drug development
    Kaitin, K. I.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 210 - 212
  • [2] Opportunities and obstacles to the development of nanopharmaceuticals for human use
    Koopaei, Nasser Nassiri
    Abdollahi, Mohammad
    [J]. DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 24
  • [3] Opportunities and obstacles to the development of nanopharmaceuticals for human use
    Nasser Nassiri Koopaei
    Mohammad Abdollahi
    [J]. DARU Journal of Pharmaceutical Sciences, 24
  • [4] OBSTACLES AND OPPORTUNITIES
    LARSON, RE
    [J]. JOURNAL OF ACCOUNTANCY, 1986, 161 (01): : 126 - 128
  • [5] Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use
    Nasser Nassiri Koopaei
    Mohammad Abdollahi
    [J]. DARU Journal of Pharmaceutical Sciences, 24
  • [6] NEW SCIENTIFIC OPPORTUNITIES AND OLD OBSTACLES IN VACCINE DEVELOPMENT
    WARREN, KS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (24) : 9275 - 9277
  • [7] Obstacles and Opportunities for Cholinergic Drug Development in the Treatment of Cognitive Disorders
    Schroeder, Rachel A.
    Wecker, Lynn
    Philpot, Rex M.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (14) : 1981 - 1985
  • [8] OPPORTUNITIES AND OBSTACLES.
    Anon
    [J]. Practical lubrication & maintenance, 1986, 9 (04): : 24 - 26
  • [9] Rifamycins - Obstacles and opportunities
    Aristoff, Paul A.
    Garcia, George A.
    Kirchhoff, Paul D.
    Showalter, H. D. Hollis
    [J]. TUBERCULOSIS, 2010, 90 (02) : 94 - 118
  • [10] OPPORTUNITIES, OBLIGATIONS AND OBSTACLES
    VARDON, S
    [J]. AUSTRALIAN JOURNAL OF PUBLIC ADMINISTRATION, 1987, 46 (02) : 142 - 145
12345